Find Federal Grants
Centers for Disease Control and Prevention - ERA · RFA-JG-25-137
Monitoring, Operations Research, Evaluation of Tools for Malaria Control and Prevention in Kenya
Centers for Disease Control and Prevention - ERA · RFA-CK-25-035
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-290
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
National Institutes of Health · PAR-25-291
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
National Institutes of Health · PAR-25-226
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
National Institutes of Health · PAR-25-282
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-281
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-26-020
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-26-019
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
National Institutes of Health · RFA-HL-26-018
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-26-017
Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (AT LASt) (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-24-076
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-171
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-26-016
Tribal Management Grant Program
Indian Health Service · HHS-2025-IHS-TMD-0001
Centers for Disease Control and Prevention - ERA · RFA-OH-25-003
BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed)
National Institutes of Health · RFA-NS-25-016
Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional)
National Institutes of Health · PAR-25-278
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)
National Institutes of Health · PA-25-295
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
National Institutes of Health · PA-25-294